(PRWEB) November 28, 2012
Over the past year, many women may have seen television and Internet ads regarding transvaginal mesh devices and their complications. This article is to provide users of such devices information regarding why you may be entitled to compensation for injuries caused by these dangerous devices. Surgical mesh is a woven fabric to repair, strengthen and reinforce weakened tissue. It is typically used in the transvaginal repair of pelvic organ prolapse (POP) and as slings for stress urinary incontinence (SUI). POP is a condition when one of the pelvic organs such as the uterus, bladder or rectum moves or prolapses and pushes against the wall of the vagina. Surgeons implant the mesh to hold these pelvic organs in place and strengthen the supporting tissue. In treating SUI, doctors use the mesh to support the urinary bladder and/or the urethra.
Unfortunately, the mesh products have caused a host of medical injuries. The FDA has issued multiple warnings and safety alerts regarding the serious complications associated with mesh devices. Some of the most common injuries incurred are: severe vaginal and pelvic pain, painful intercourse, chronic infections, recurrence of pelvic organ collapse, incontinence, and mesh erosion into the bladder, uterus, vagina and other organs. Erosion of the mesh into nearby tissues and organs and extrusion of the mesh where pieces of the synthetic mesh erode through the vaginal wall are among the most painful complications, often causing multiple corrective surgeries to remove the devices. Adding to the problem is the fact that this mesh was never tested for vaginal repairs. The FDA’s fast-track approval system, called the 510(k), didn’t require testing prior to its market release.
There are multiple manufacturers of transvaginal mesh devices and most, if not all, are involved in litigation over their defective products. These manufacturers include: C.R. Bard, Gynecare, Ethicon, Johnson & Johnson, American Medical Systems, Boston Scientific, Mentor Corporation and Tyco Covidien.
The transvaginal mesh cases are currently pending in several federal and state courts. The first Bellwether cases are set for trial in February and June 2013 in the U.S. District court in West Virginia before the Judge Goodwin. American Medical Systems, Inc. (MDL 2325); In re: Boston Scientific Corp. (MDL No. 2326); and In re: Ethicon, Inc. (MDL No. 2327). Bellwether trials occur in complex medical device and drug litigation wherein a number of lawsuits have been filed involving similar allegations. The verdicts in these early cases provide insight how juries will likely respond to evidence that will be presented in multiple cases.
Who may qualify for compensation for a mesh related claim?
Women who have suffered significant injuries following a transvaginal mesh implant may be entitled to compensation for their injuries. The merits of your case are based upon several factors including when your mesh product was implanted, how soon afterword you suffered side effects, the types of injuries sustained, the types of warnings you received prior to surgery and the technique used by the surgeon.
How to Hire an Attorney
Hiring an attorney is not a difficult or expensive experience. Attorneys handling personal injury litigation as described above work on a contingency fee agreement. This means the attorney receives a percentage of the recovery received in the litigation. If there is no recovery by the client, there are no fees or costs charged to the client. Consultations to determine whether a client has a case are also free.
Ennis & Ennis, P.A. continues to offer free, nationwide, confidential consultations to anyone who was injured by a transvaginal mesh device by calling toll free 1-800-856-6405 or by going to http://www.ennislaw.com and completing an online case evaluation form.
Ennis & Ennis, P.A. is a nationwide law firm with offices in Ft. Lauderdale, Miami and Washington D.C. that concentrates its practice in mass torts and represents individuals against pharmaceutical companies and medical device makers.